Assessment of macrophage migration inhibitory factor in patients with verruca vulgaris
- PMID: 31686887
- PMCID: PMC6709820
- DOI: 10.2147/CCID.S209269
Assessment of macrophage migration inhibitory factor in patients with verruca vulgaris
Abstract
Background: Common warts are caused by human papillomaviruses (HPVs), they are among the most common cutaneous viral infections. Macrophage migration inhibitory factor (MIF) is an essential contributor in many inflammatory and immune skin diseases. Yet, its role in the pathology of common warts is unclear.
Objective: To assess MIF levels in lesional and perilesional skin in patients with common warts in comparison to apparently healthy control group with matching age and sex.
Subjects and methods: A case-control study performed on 60 patients with common warts (group A) and 30 age and sex matching healthy controls (group B). Two biopsies were taken from each patient in group A; one from the lesion (lesional) and the other one from the skin around the wart (perilesional), while biopsies of controls were taken from matched sites to patients. Measurement of MIF in all groups was done by quantitative ELISA kits.
Results: Significant high MIF levels were detected in lesional and perilesional skin biopsies compared to controls (P<0.001). Yet, the difference in MIF levels between lesional and perilesional skin biopsy was non-significant. No significant relations were found between lesional and perilesional MIF levels and clinical characteristics of the studied patients while both lesional and perilesional MIF levels were significantly correlated (rh=0.269, P=0.021).
Conclusion: The significantly elevated MIF levels in lesional and perilesional skin biopsies compared to controls point to its role in wart progression from HPV infected cells.
Keywords: common warts; human papillomavirus; macrophage migration inhibitory factor.
© 2019 Sorour et al.
Conflict of interest statement
All authors declare no conflicts of interest in this work.
Similar articles
-
Expression Patterns of Macrophage Migration Inhibitory Factor and Its Gene Variants (MIF-173 G˃C) in Verruca Vulgaris.Clin Cosmet Investig Dermatol. 2022 Jun 10;15:1073-1085. doi: 10.2147/CCID.S363916. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35712358 Free PMC article.
-
Possible role of interleukin-17 and macrophage migration inhibitory factor in cutaneous warts.J Cosmet Dermatol. 2018 Dec;17(6):1250-1253. doi: 10.1111/jocd.12472. Epub 2017 Dec 18. J Cosmet Dermatol. 2018. PMID: 29250927
-
Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris.Braz J Med Biol Res. 2013 May;46(5):460-4. doi: 10.1590/S0100-879X2012007500152. Braz J Med Biol Res. 2013. PMID: 23797494 Free PMC article.
-
Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata.Int J Dermatol. 2016 Dec;55(12):1357-1361. doi: 10.1111/ijd.13344. Epub 2016 Jul 15. Int J Dermatol. 2016. PMID: 27420731
-
Role of macrophage migration inhibitory factor (MIF) in the skin.J Dermatol Sci. 2005 Feb;37(2):65-73. doi: 10.1016/j.jdermsci.2004.08.007. J Dermatol Sci. 2005. PMID: 15659324 Review.
Cited by
-
The Role of Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (D-DT/MIF-2) in Infections: A Clinical Perspective.Biomedicines. 2023 Dec 19;12(1):2. doi: 10.3390/biomedicines12010002. Biomedicines. 2023. PMID: 38275363 Free PMC article. Review.
-
Expression Patterns of Macrophage Migration Inhibitory Factor and Its Gene Variants (MIF-173 G˃C) in Verruca Vulgaris.Clin Cosmet Investig Dermatol. 2022 Jun 10;15:1073-1085. doi: 10.2147/CCID.S363916. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35712358 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous